Impact of sodium–glucose cotransporter 2 inhibitors on renal function in participants with type 2 diabetes and chronic kidney disease with normoalbuminuria

BACKGROUND: We compared the effects of sodium–glucose cotransporter 2 (SGLT2) inhibitors on renal function in participants with type 2 diabetes and chronic kidney disease (CKD) classified by degree of albuminuria. METHODS: A retrospective review of the clinical records of Japanese participants with...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Diabetol Metab Syndr
Egile Nagusiak: Nakamura, Akinobu, Miyoshi, Hideaki, Kameda, Hiraku, Yamashita, Kumiko, Kurihara, Yoshio
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2020
Gaiak:
Short Report
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6954503/
https://ncbi.nlm.nih.gov/pubmed/31938043
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13098-020-0516-9
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak